Iristectorigenin BCAS# 39012-01-6 |
- Iristectorigenin A
Catalog No.:BCN8393
CAS No.:86849-77-6
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 39012-01-6 | SDF | Download SDF |
| PubChem ID | 5491637 | Appearance | White powder |
| Formula | C17H14O7 | M.Wt | 330.3 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 5,7-dihydroxy-3-(4-hydroxy-3-methoxyphenyl)-6-methoxychromen-4-one | ||
| SMILES | COC1=C(C=CC(=C1)C2=COC3=CC(=C(C(=C3C2=O)O)OC)O)O | ||
| Standard InChIKey | CCRPIWFQMLICCY-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C17H14O7/c1-22-12-5-8(3-4-10(12)18)9-7-24-13-6-11(19)17(23-2)16(21)14(13)15(9)20/h3-7,18-19,21H,1-2H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Iristectorigenin B Dilution Calculator
Iristectorigenin B Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.0276 mL | 15.1378 mL | 30.2755 mL | 60.551 mL | 75.6888 mL |
| 5 mM | 0.6055 mL | 3.0276 mL | 6.0551 mL | 12.1102 mL | 15.1378 mL |
| 10 mM | 0.3028 mL | 1.5138 mL | 3.0276 mL | 6.0551 mL | 7.5689 mL |
| 50 mM | 0.0606 mL | 0.3028 mL | 0.6055 mL | 1.211 mL | 1.5138 mL |
| 100 mM | 0.0303 mL | 0.1514 mL | 0.3028 mL | 0.6055 mL | 0.7569 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- (+)-Puerol B 2''-O-glucoside
Catalog No.:BCN4561
CAS No.:868409-19-2
- Protosappanin A dimethyl acetal
Catalog No.:BCN6517
CAS No.:868405-37-2
- 2,2,5,5-Tetramethylcyclohexane-1,4-dione
Catalog No.:BCN1324
CAS No.:86838-54-2
- WAY 213613
Catalog No.:BCC7442
CAS No.:868359-05-1
- Rhodiosin; Herbacetin-7-O-glucorhamnoside
Catalog No.:BCN8478
CAS No.:86831-54-1
- Rhodiolin
Catalog No.:BCC8356
CAS No.:86831-53-0
- Org 27569
Catalog No.:BCC4411
CAS No.:868273-06-7
- LY 2365109 hydrochloride
Catalog No.:BCC7677
CAS No.:868265-28-5
- Pam2CSK4
Catalog No.:BCC6247
CAS No.:868247-72-7
- SID 7969543
Catalog No.:BCC6026
CAS No.:868224-64-0
- Carasiphenol C
Catalog No.:BCN8251
CAS No.:868168-04-1
- H-Cys-OEt.HCl
Catalog No.:BCC2904
CAS No.:868-59-7
- Carfilzomib (PR-171)
Catalog No.:BCC1145
CAS No.:868540-17-4
- 3',5'-Dimethoxybiphenyl-3-ol
Catalog No.:BCN7529
CAS No.:868666-20-0
- (R)-(-)-α-Methylhistamine dihydrobromide
Catalog No.:BCC5665
CAS No.:868698-49-1
- Umeclidinium bromide
Catalog No.:BCC2022
CAS No.:869113-09-7
- Eudesma-3,11-dien-2-one
Catalog No.:BCN7607
CAS No.:86917-79-5
- SB 203580 hydrochloride
Catalog No.:BCC4293
CAS No.:869185-85-3
- PF-573228
Catalog No.:BCC4496
CAS No.:869288-64-2
- Neurokinin A (porcine)
Catalog No.:BCC6955
CAS No.:86933-74-6
- Neurokinin B (human, porcine)
Catalog No.:BCC7119
CAS No.:86933-75-7
- AZD8330
Catalog No.:BCC3733
CAS No.:869357-68-6
- MLN8054
Catalog No.:BCC2170
CAS No.:869363-13-3
- 14-Deoxy-17-hydroxyandrographolide
Catalog No.:BCN4560
CAS No.:869384-82-7
Methyl caffeate and some plant constituents inhibit age-related inflammation: effects on senescence-associated secretory phenotype (SASP) formation.[Pubmed:28299617]
Arch Pharm Res. 2017 Apr;40(4):524-535.
During aging, cells secrete molecules called senescence-associated secretory phenotype (SASP). They constitute chronic low-grade inflammation environment to adjacent cells and tissues. In order to find inhibiting agents of SASP formation, 113 plant constituents were incubated with BJ fibroblasts for 6 days after treatment with bleomycin. Several plant constituents showed considerable inhibition of IL-6 production, a representative SASP marker. These plant constituents included anthraquinones such as aurantio-obtusin, flavonoids including astragalin, iristectorigenin A, Iristectorigenin B, linarin, lignans including lariciresinol 9-O-glucoside and eleutheroside E, phenylpropanoids such as caffeic acid and methyl caffeate, steroid (ophiopogonin), and others like centauroside, rhoifolin and scoparone. In particular, methyl caffeate down-regulated SASP factors such as IL-1alpha, IL-1beta, IL-6, IL-8, GM-CSF, CXCL1, MCP-2, and MMP-3. Inhibition of these SASP mRNA expression levels also coincided with the reduction of IkappaBzeta expression and NF-kappaB p65 activation without affecting the expression levels of senescence markers, p21 or pRb. Taken together, the present study demonstrated that methyl caffeate might be a specific and strong inhibitor of SASP production without affecting the aging process. Its action mechanisms involve the reduction of IkappaBzeta expression and NF-kappaB p65 activation. Therefore, this compound might be effective in alleviating chronic low-grade inflammation linked to age-related degenerative disorders.
Iristectorigenin B isolated from Belamcanda chinensis is a liver X receptor modulator that increases ABCA1 and ABCG1 expression in macrophage RAW 264.7 cells.[Pubmed:23011313]
Biotechnol Lett. 2012 Dec;34(12):2213-21.
A novel liver X receptor (LXR) modulator, Iristectorigenin B isolated from Belamcanda chinensis, stimulated the transcriptional activity of both LXR-alpha and LXR-beta. In macrophages, Iristectorigenin B suppressed cholesterol accumulation in a dose-dependent manner and induced the transcriptional activation of LXR-alpha/-beta-responsive genes, ATP-binding cassette transporters A1 and G1. It did not induce hepatic lipid accumulation nor the expression of the lipogenesis genes sterol regulatory element-binding protein-1c, fatty acid synthase, and stearoyl-CoA desaturase-1. Iristectorigenin B thus is a dual-LXR agonist that regulates the expression of key genes in cholesterol homeostasis in macrophage cells without inducing hepatic lipid accumulation.
